Low Direct Cytotoxicity of Nabumetone on Gastric Mucosal Cells-Reference-Cited by-同舟云学术

Low Direct Cytotoxicity of Nabumetone on Gastric Mucosal Cells

Published:2005-09 Issue:9 Volume:50 Page:1641-1646
ISSN:0163-2116
Container-title:Digestive Diseases and Sciences
language:en
Short-container-title:Dig Dis Sci

Author:

Arai Yasuhiro,Tanaka Ken-Ichiro,Ushijima Hironori,Tomisato Wataru,Tsutsumi Shinji,Aburaya Mayuko,Hoshino Tatsuya,Yokomizo Kazumi,Suzuki Keitarou,Katsu Takashi,Tsuchiya Tomofusa,Mizushima Tohru

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Physiology

Link

http://link.springer.com/content/pdf/10.1007/s10620-005-2909-x.pdf

Reference33 articles.

1. Hawkey CJ: Nonsteroidal anti-inflammatory drug gastropathy. Gastroenterology 119:521–535, 2000

2. Gabriel SE, Jaakkimainen L, Bombardier C: Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. Ann Int Med 115:787–796, 1991

3. Kurata JH, Abbey DE: The effect of chronic aspirin use on duodenal and gastric ulcer hospitalizations. J Clin Gastroenterol 12:260–266, 1990

4. Miller TA: Protective effects of prostaglandins against gastric mucosal damage: current knowledge and proposed mechanisms. Am J Physiol 245:G601–G623, 1983

5. Vane J: Towards a better aspirin. Nature 367:215–216, 1994

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interactions of Analgesics with Cisplatin: Modulation of Anticancer Efficacy and Potential Organ Toxicity;Medicina;2021-12-28

2. Repurposed drugs and nutraceuticals targeting envelope protein: A possible therapeutic strategy against COVID-19;Genomics;2021-01

3. A novel injection strategy of flurbiprofen axetil by inhibiting protein binding with 6-methoxy-2-naphthylacetic acid;European Journal of Drug Metabolism and Pharmacokinetics;2014-12-24

4. Molecular Mechanism for Various Pharmacological Activities of NSAIDS;Pharmaceuticals;2010-05-25

5. Comparative clinical trial of S-adenosylmethionine versus nabumetone for the treatment of knee osteoarthritis: An 8-week, multicenter, randomized, double-blind, double-dummy, Phase IV study in Korean patients;Clinical Therapeutics;2009-12